FI906368A0 - Makrocykliska bifunktionella kelatbildare, komplex daerav och deras antikroppkonjugat - Google Patents

Makrocykliska bifunktionella kelatbildare, komplex daerav och deras antikroppkonjugat

Info

Publication number
FI906368A0
FI906368A0 FI906368A FI906368A FI906368A0 FI 906368 A0 FI906368 A0 FI 906368A0 FI 906368 A FI906368 A FI 906368A FI 906368 A FI906368 A FI 906368A FI 906368 A0 FI906368 A0 FI 906368A0
Authority
FI
Finland
Prior art keywords
biffunction
macrocyclic
children
computer
complexes
Prior art date
Application number
FI906368A
Other languages
English (en)
Other versions
FI103792B1 (fi
FI103792B (fi
Inventor
Roberta C Cheng
William A Fordyce
William F Goeckeler
Jr William J Kruper
Sharon Baughman
Joseph R Garlich
Garry E Kiefer
Kenneth Mcmillan
Jaime Simon
David A Wilson
Richard Keith Frank
Original Assignee
Dow Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Chemical Co filed Critical Dow Chemical Co
Publication of FI906368A0 publication Critical patent/FI906368A0/fi
Priority to FI953708A priority Critical patent/FI104898B/fi
Application granted granted Critical
Publication of FI103792B1 publication Critical patent/FI103792B1/fi
Publication of FI103792B publication Critical patent/FI103792B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0482—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group chelates from cyclic ligands, e.g. DOTA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1084—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody the antibody being a hybrid immunoglobulin
    • A61K51/109—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody the antibody being a hybrid immunoglobulin immunoglobulins having two or more different antigen-binding sites or multifunctional antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI906368A 1988-06-24 1990-12-21 Makrosyklisiä bifunktionaalisia kelaatinmuodostajayhdisteitä, niiden metallikomplekseja sekä näiden kompleksien vasta-ainekonjugaatteja FI103792B (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI953708A FI104898B (fi) 1988-06-24 1995-08-03 Menetelmä terapeuttisesti aktiivisen metallikompleksiyhdisteen valmistamiseksi

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US21149688A 1988-06-24 1988-06-24
US21149688 1988-06-24
US37095689A 1989-06-21 1989-06-21
US37095689 1989-06-21
US8902788 1989-06-23
PCT/US1989/002788 WO1989012631A1 (en) 1988-06-24 1989-06-23 Macrocyclic bifunctional chelants, complexes thereof and their antibody conjugates

Publications (3)

Publication Number Publication Date
FI906368A0 true FI906368A0 (fi) 1990-12-21
FI103792B1 FI103792B1 (fi) 1999-09-30
FI103792B FI103792B (fi) 1999-09-30

Family

ID=26906194

Family Applications (2)

Application Number Title Priority Date Filing Date
FI906368A FI103792B (fi) 1988-06-24 1990-12-21 Makrosyklisiä bifunktionaalisia kelaatinmuodostajayhdisteitä, niiden metallikomplekseja sekä näiden kompleksien vasta-ainekonjugaatteja
FI982303A FI117889B (fi) 1988-06-24 1998-10-23 Menetelmä terapeuttisesti aktiivisten, makrosyklisten bifunktionaalisten kelaatinmuodostajien komplekseja sisältävien vasta-ainekonjugaattien valmistamiseksi

Family Applications After (1)

Application Number Title Priority Date Filing Date
FI982303A FI117889B (fi) 1988-06-24 1998-10-23 Menetelmä terapeuttisesti aktiivisten, makrosyklisten bifunktionaalisten kelaatinmuodostajien komplekseja sisältävien vasta-ainekonjugaattien valmistamiseksi

Country Status (20)

Country Link
US (1) US5435990A (fi)
EP (2) EP0353450B1 (fi)
JP (1) JP2831073B2 (fi)
KR (1) KR0137930B1 (fi)
AT (1) ATE120457T1 (fi)
AU (1) AU634167B2 (fi)
BR (1) BR8907507A (fi)
CA (1) CA1341373C (fi)
DE (2) DE353450T1 (fi)
DK (1) DK175393B1 (fi)
ES (1) ES2013978A4 (fi)
FI (2) FI103792B (fi)
GR (1) GR900300034T1 (fi)
HK (1) HK60696A (fi)
HU (1) HU219485B (fi)
IE (1) IE67273B1 (fi)
IL (1) IL90730A0 (fi)
NO (1) NO179008C (fi)
NZ (1) NZ229700A (fi)
WO (1) WO1989012631A1 (fi)

Families Citing this family (105)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5250285A (en) * 1985-05-08 1993-10-05 The General Hospital Corporation Hydroxy-aryl metal chelates for diagnostic NMR imaging
US5422096A (en) * 1985-05-08 1995-06-06 The General Hospital Corporation Hydroxy-aryl metal chelates for diagnostic NMR imaging
WO1989010758A1 (en) * 1988-05-02 1989-11-16 Zynaxis Technologies, Inc. Compounds, compositions and method for binding bio-affecting substances to surface membranes of bio-particles
US5756065A (en) * 1988-06-24 1998-05-26 The Dow Chemical Company Macrocyclic tetraazacyclododecane conjugates and their use as diagnostic and therapeutic agents
JP2930708B2 (ja) * 1988-12-23 1999-08-03 ザ ダウ ケミカル カンパニー イソチオシアナト官能化金属錯体の製造方法
US5914095A (en) * 1989-04-07 1999-06-22 Salutar, Inc. Polychelants containg amide bonds
US5686410A (en) * 1989-07-20 1997-11-11 Novartis Ag Polypeptide derivatives
EP0489869B1 (en) * 1989-08-28 1998-11-11 The General Hospital Corporation Hydroxy-aryl metal chelates for diagnostic nmr imaging
DE3938992A1 (de) * 1989-11-21 1991-05-23 Schering Ag Kaskadenpolymer-gebundene komplexbildner, deren komplexe und konjugate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
US5410043A (en) * 1991-12-06 1995-04-25 Schering Aktiengesellschaft Process for the production of mono-N-substituted tetraaza macrocycles
AU663572B2 (en) * 1992-03-27 1995-10-12 Nihon Medi-Physics Co., Ltd. Tetraazacyclododecane derivative and its use
WO1993020852A2 (en) * 1992-04-13 1993-10-28 The Dow Chemical Company Macrocyclic chelating agents, chelates and conjugates thereof
US5310535A (en) * 1992-04-24 1994-05-10 The Dow Chemical Company Carboxamide modified polyamine chelators and radioactive complexes thereof for conjugation to antibodies
DE4218744C2 (de) * 1992-06-04 1997-11-06 Schering Ag Verfahren zur Herstellung von N-ß-Hxdroxyalkyl-tri-N-carboxylalkyl-1,4,7,10-tetraazacyclododecan- und N-ß-Hydroxyalkyl-tri-N-carboxyalkyl-1,4,8,11-tetraazacyclotetradecan-Derivaten und deren Metallkomplexe
US5505931A (en) * 1993-03-04 1996-04-09 The Dow Chemical Company Acid cleavable compounds, their preparation and use as bifunctional acid-labile crosslinking agents
US5462725A (en) * 1993-05-06 1995-10-31 The Dow Chemical Company 2-pyridylmethylenepolyazamacrocyclophosphonic acids, complexes and derivatives thereof, for use as contrast agents
DE69426811T2 (de) * 1993-12-30 2001-09-13 Guerbet, Villepinte Polyaminierte Liganden, Metallkomplexe, Verfahren zur Herstellung und diagnostische und therapeutische Verwendungen
CA2180662A1 (en) * 1994-01-07 1995-07-13 Ramaswamy Subramanian New polyaminocarboxylate chelators
WO1995026206A1 (en) * 1994-03-28 1995-10-05 The Regents Of The University Of California Method for preparing radionuclide-labeled chelating agent-ligand complexes
US5582814A (en) * 1994-04-15 1996-12-10 Metasyn, Inc. 1-(p-n-butylbenzyl) DTPA for magnetic resonance imaging
US6693190B1 (en) 1994-05-11 2004-02-17 Bracco International B.V. Enhanced relaxivity monomeric and multimeric compounds
KR100367264B1 (ko) * 1994-09-07 2003-03-15 더 다우 케미칼 캄파니 거대환상킬레이트화제의제조방법및킬레이트의형성방법,및그방법에의해제조된결합체
US7597886B2 (en) * 1994-11-07 2009-10-06 Human Genome Sciences, Inc. Tumor necrosis factor-gamma
US7820798B2 (en) * 1994-11-07 2010-10-26 Human Genome Sciences, Inc. Tumor necrosis factor-gamma
TW319763B (fi) 1995-02-01 1997-11-11 Epix Medical Inc
DE19505960A1 (de) * 1995-02-21 1996-08-22 Deutsches Krebsforsch Konjugat zur individuellen Dosierung von Arzneimitteln
TR28540A (tr) * 1995-03-16 1996-09-30 Guerbet Sa Poliamine edilmis baglayicilar ve bunlarin metal kompleksleri.
EP0955044B1 (en) * 1995-06-26 2005-11-16 Chelator LLC Method of inhibiting bacterial or fungal growth using a complexing agent
US6348581B1 (en) 1996-10-31 2002-02-19 The Dow Chemical Company High affinity humanized anti-TAG-72 monoclonalantibodies
WO1999043287A2 (en) * 1998-02-25 1999-09-02 Biotraces, Inc. Phosphate-based dendrimers for bioassays
US6231832B1 (en) 1998-03-23 2001-05-15 Brookhaven Science Associates Radiopharmaceutical stannic Sn-117m chelate compositions and methods of use
US6040124A (en) * 1998-11-20 2000-03-21 Eastman Kodak Company Imaging element with biaxially oriented sheet with fluoropolymer
AU3501700A (en) 1999-02-26 2000-09-14 Human Genome Sciences, Inc. Human endokine alpha and methods of use
US6696551B1 (en) 1999-03-23 2004-02-24 The United States Of America As Represented By The Department Of Health And Human Services 225Ac-HEHA and related compounds, methods of synthesis and methods of use
LU90544B1 (en) * 2000-03-14 2001-09-17 Europ Economic Community Bifunctional chelating agent
EP1278544A4 (en) 2000-04-12 2004-08-18 Human Genome Sciences Inc ALBUMIN FUSION PROTEINS
WO2001096528A2 (en) 2000-06-15 2001-12-20 Human Genome Sciences, Inc. Human tumor necrosis factor delta and epsilon
WO2002002641A1 (en) 2000-06-16 2002-01-10 Human Genome Sciences, Inc. Antibodies that immunospecifically bind to blys
AU2002327164A1 (en) * 2001-01-29 2002-12-09 Idec Pharmaceuticals Corporation Engineered tetravalent antibodies and methods of use
MXPA03006771A (es) * 2001-01-29 2004-05-05 Idec Pharma Corp Anticuerpos modificados y metodos de uso.
US6670456B2 (en) * 2001-02-28 2003-12-30 Dow Global Technologies Inc. Actinium-225 complexes and conjugates for targeted radiotherapy
MXPA03010747A (es) 2001-05-25 2004-03-02 Human Genome Sciences Inc Anticuerpos que se unen inmunoespecificamente a receptores de ligando inductor de apoptosis relacionado con factor de necrosis tumoral.
DE10135356C1 (de) * 2001-07-20 2003-04-17 Schering Ag Makrocyclische Metallkomplexe und deren Verwendung zur Herstellung von Konjugaten mit Biomolekülen
US20080194481A1 (en) 2001-12-21 2008-08-14 Human Genome Sciences, Inc. Albumin Fusion Proteins
EP2277910A1 (en) 2001-12-21 2011-01-26 Human Genome Sciences, Inc. Albumin fusion proteins
EP1497445A2 (en) * 2002-04-01 2005-01-19 Human Genome Sciences, Inc. Antibodies that specifically bind to gmad
EP1499352A4 (en) 2002-04-12 2006-10-11 Medimmune Inc ANTI-INTERLEUKIN-9 RECOMBINANT ANTIBODIES
CN100418981C (zh) 2002-06-10 2008-09-17 瓦西尼斯公司 在乳腺癌和膀胱癌中差异表达的基因及编码多肽
US20030086868A1 (en) * 2002-08-12 2003-05-08 Dangshe Ma Actinium-225 complexes and conjugates for radioimmunotherapy
US7214545B2 (en) * 2003-04-28 2007-05-08 The Regents Of The University Of California Element-coded affinity tags
CA2533878A1 (en) * 2003-07-29 2005-09-22 Immunomedics, Inc. Fluorinated carbohydrate conjugates
AU2004263136A1 (en) * 2003-08-08 2005-02-17 Barnes-Jewish Hospital Emulsion particles for imaging and therapy and methods of use thereof
JP4912153B2 (ja) 2003-12-01 2012-04-11 イミューノメディクス、インコーポレイテッド タンパク質とキレート剤とのコンジュゲートを調製するための改良された方法
CN1913921B (zh) * 2003-12-04 2012-02-22 瓦西尼斯公司 通过靶定暴露在细胞凋亡肿瘤细胞上的内部抗原杀死肿瘤细胞的方法
EP1718749A4 (en) * 2004-02-06 2007-07-18 Nymox Corp ANTI-AF-20 HUMANIZED MONOCLONAL ANTIBODY
PL1729795T3 (pl) 2004-02-09 2016-08-31 Human Genome Sciences Inc Białka fuzyjne albuminy
EP1786463A4 (en) * 2004-03-26 2009-05-20 Human Genome Sciences Inc ANTIBODY AGAINST NOGO RECEPTOR
WO2005122891A1 (en) 2004-06-09 2005-12-29 Kereos, Inc. Lipophilic derivatives of chelate monoamides
WO2006020779A2 (en) * 2004-08-10 2006-02-23 Dow Global Technologies Inc. Targeting chelants and chelates
CN101198624B (zh) 2005-05-06 2012-10-10 津莫吉尼蒂克斯公司 Il-31单克隆抗体及使用方法
EP1954319A2 (en) * 2005-11-29 2008-08-13 Mallinckrodt, Inc. Bifunctional metal chelating conjugates
CA2643145C (en) * 2006-02-24 2014-04-29 Mallinckrodt Inc. Bifunctional resorcinol, thioresorcinol, and dithioresorcinol derivative metal chelating conjugates
EP1999118B1 (en) 2006-03-14 2012-10-17 Mallinckrodt LLC Metal complexes of tetraazamacrocycle derivatives
KR20080103562A (ko) * 2006-03-15 2008-11-27 말린크로트, 인코포레이티드 치환된 방향족 잔기 및 그의 유도체를 갖는 킬레이팅 컨쥬게이트
NZ571068A (en) 2006-03-21 2012-06-29 Genentech Inc An antibody that can bind human alpha5beta1
CN101505793A (zh) * 2006-06-22 2009-08-12 瓦西尼斯公司 用于治疗癌症的抗c35抗体
CA2659251C (en) 2006-07-10 2016-06-14 The Regents Of The University Of California Luminescent 1-hydroxy-2-pyridinone chelates of lanthanides
CA2660175C (en) 2006-09-01 2015-05-12 Zymogenetics, Inc. Variable region sequences of il-31 monoclonal antibodies and methods of use
CA2670061A1 (en) * 2006-11-21 2008-06-12 Barnes-Jewish Hospital Methods of imaging employing chelating agents
GB0624587D0 (en) * 2006-12-08 2007-01-17 Univ Muenchen Tech Chelating agent
US8507199B2 (en) * 2007-01-25 2013-08-13 Lumiphore, Inc. Multi-color time resolved fluorophores based on macrocyclic lanthanide complexes
WO2008105473A1 (ja) * 2007-02-28 2008-09-04 National University Corporation Chiba University 抗悪性腫瘍薬
JP2010531666A (ja) 2007-06-26 2010-09-30 ユニバーシティ オブ マイアミ 抗体−エンドスタチン融合タンパク質及びそのバリアント
EA020457B1 (ru) 2007-12-07 2014-11-28 Займоджинетикс, Инк. Молекулы гуманизированных антител, специфичных к il-31
AU2008341050B2 (en) 2007-12-26 2013-10-24 Vaccinex, Inc. Anti-C35 antibody combination therapies and methods
JP2009215238A (ja) * 2008-03-11 2009-09-24 Osaka Univ 希土類発光プローブ
KR20110008086A (ko) 2008-04-11 2011-01-25 메리맥 파마슈티컬즈, 인크. 인간 혈청 알부민 링커 및 그 콘쥬게이트
WO2010000714A2 (en) * 2008-07-04 2010-01-07 Oslo Universitetssykehus Hf Radioimmunoconjugate kit
US20100151591A1 (en) * 2008-10-31 2010-06-17 Butlin Nathaniel G Rapid homogeneous diagnostic testing platform based on lanthanide fluorescent resonance energy transfer
PE20120770A1 (es) 2009-03-25 2012-07-10 Genentech Inc ANTICUERPOS ANTI alfa5ß1 CON ACTIVIDAD SOBRE GLIOBLASTOMAS
EP2470513B1 (en) 2009-08-24 2014-10-08 Lumiphore, Inc. Macrocyclic hopo chelators
EP2516407A4 (en) * 2009-12-24 2013-06-12 Lumiphore Inc RADIOPHARMACEUTICAL COMPLEXES
KR101253100B1 (ko) 2010-02-16 2013-04-10 경북대학교 산학협력단 폴리아자마크로사이클릭 화합물, 그 제조 방법 및 생의학적 적용
EP2569335B1 (en) 2010-05-14 2018-08-22 Orega Biotech Methods of treating and/or preventing cell proliferation disorders with il-17 antagonists
US11453652B2 (en) 2013-03-15 2022-09-27 Lumiphore, Inc. Di-macrocycles
JP6691872B2 (ja) 2014-05-30 2020-05-13 ヘンリクス バイオテック カンパニー リミテッド 抗上皮増殖因子受容体（ｅｇｆｒ）抗体
CN106573961B (zh) 2014-06-20 2022-01-04 豪夫迈·罗氏有限公司 基于chagasin的支架组合物、方法和应用
ES2830392T3 (es) 2014-07-23 2021-06-03 Ohio State Innovation Foundation Métodos y composiciones relacionados con fragmentos de anticuerpo que se unen a la glicoproteína 72 asociada a tumores (TAG-72)
GB201421162D0 (en) * 2014-11-28 2015-01-14 Ge Healthcare As Lanthanide complex formulations
SG10201913158PA (en) 2015-04-03 2020-02-27 Eureka Therapeutics Inc Constructs targeting afp peptide/mhc complexes and uses thereof
JP6952605B2 (ja) 2015-04-24 2021-10-20 ジェネンテック， インコーポレイテッド 多特異性抗原結合タンパク質
EP4339615A3 (en) 2016-09-16 2024-05-22 Shanghai Henlius Biotech, Inc. Anti-pd-1 antibodies
EP3568468A4 (en) 2017-01-12 2020-12-30 Eureka Therapeutics, Inc. RECOMBINATION PRODUCTS TARGETING PEPTIDE HISTONE H3 / MHC COMPLEXES AND THEIR USES
SG11201909728XA (en) 2017-04-26 2019-11-28 Eureka Therapeutics Inc Constructs specifically recognizing glypican 3 and uses thereof
FR3069245B1 (fr) * 2017-07-21 2019-07-26 Guerbet Ligands macrocycliques lipophiles, leurs complexes ainsi que leurs utilisations medicales
US11485782B2 (en) 2018-03-14 2022-11-01 Beijing Xuanyi Pharmasciences Co., Ltd. Anti-claudin 18.2 antibodies
AU2019287595A1 (en) * 2018-04-27 2020-12-03 University Of Iowa Research Foundation Compositions for chelating metals at low temperatures
SG11202012342WA (en) 2018-06-18 2021-01-28 Eureka Therapeutics Inc Constructs targeting prostate-specific membrane antigen (psma) and uses thereof
MX2021013667A (es) * 2019-05-10 2022-01-31 Janssen Biotech Inc Quelantes macrocíclicos y métodos de uso de estos.
CN112300279A (zh) 2019-07-26 2021-02-02 上海复宏汉霖生物技术股份有限公司 针对抗cd73抗体和变体的方法和组合物
CN110818795B (zh) 2020-01-10 2020-04-24 上海复宏汉霖生物技术股份有限公司 抗tigit抗体和使用方法
EP4243935A1 (en) * 2020-11-10 2023-09-20 Janssen Biotech, Inc. Macrocyclic compounds and methods of use thereof
WO2023109900A1 (en) 2021-12-17 2023-06-22 Shanghai Henlius Biotech, Inc. Anti-ox40 antibodies, multispecific antibodies and methods of use
CN118574849A (zh) 2021-12-17 2024-08-30 上海复宏汉霖生物技术股份有限公司 抗ox40抗体和使用方法
WO2023179740A1 (en) 2022-03-25 2023-09-28 Shanghai Henlius Biotech , Inc. Anti-msln antibodies and methods of use

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4647447A (en) * 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
US4472509A (en) * 1982-06-07 1984-09-18 Gansow Otto A Metal chelate conjugated monoclonal antibodies
US4454106A (en) * 1982-06-07 1984-06-12 Gansow Otto A Use of metal chelate conjugated monoclonal antibodies
SE8301395L (sv) * 1983-03-15 1984-09-16 Wallac Oy Kelatiserande foreningar med funktionella grupper vilka tillater kovalent koppling till bio-organiska molekyler
US4678667A (en) * 1985-07-02 1987-07-07 501 Regents of the University of California Macrocyclic bifunctional chelating agents
DE3772785D1 (de) * 1986-01-23 1991-10-17 Squibb & Sons Inc 1-substituiertes-4,7,10-triscarboxymethyl-1,4,7,10-tetraazacyclododecan und analoga.
US4885363A (en) * 1987-04-24 1989-12-05 E. R. Squibb & Sons, Inc. 1-substituted-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane and analogs
GB8603537D0 (en) * 1986-02-13 1986-03-19 Parker D Conjugate compound
DE3625417C2 (de) * 1986-07-28 1998-10-08 Schering Ag Tetraazacyclododecan-Derivate
US5057302A (en) * 1987-02-13 1991-10-15 Abbott Laboratories Bifunctional chelating agents
DE3713842A1 (de) * 1987-04-22 1988-11-17 Schering Ag Substituierte cyclische komplexbildner, komplexe und komplexsalze, verfahren zu deren herstellung und diese enthaltende pharmazeutische mittel
US5006643A (en) * 1987-06-24 1991-04-09 The Dow Chemical Company Process for preparing isothiocyanato functionalized metal complexes
US4994560A (en) * 1987-06-24 1991-02-19 The Dow Chemical Company Functionalized polyamine chelants and radioactive rhodium complexes thereof for conjugation to antibodies
GB8719042D0 (en) * 1987-08-12 1987-09-16 Parker D Conjugate compounds
GB8719041D0 (en) * 1987-08-12 1987-09-16 Parker D Conjugate compounds
ATE134999T1 (de) * 1988-05-25 1996-03-15 Us Commerce Makrocyclische chelate und verwendungsverfahren
ZA894792B (en) * 1988-06-24 1991-04-24 Dow Chemical Co Macrocyclic bifunctional chelants,complexes thereof and their antibody conjugates

Also Published As

Publication number Publication date
DE353450T1 (de) 1990-09-06
JP2831073B2 (ja) 1998-12-02
FI982303A (fi) 1998-10-23
US5435990A (en) 1995-07-25
HUT70200A (en) 1995-09-28
FI103792B1 (fi) 1999-09-30
DE68921941D1 (de) 1995-05-04
HK60696A (en) 1996-04-19
IL90730A0 (en) 1990-01-18
NZ229700A (en) 1993-01-27
NO179008C (no) 1996-07-17
IE67273B1 (en) 1996-03-20
DE68921941T2 (de) 1995-07-27
KR0137930B1 (en) 1998-05-15
FI982303A0 (fi) 1998-10-23
FI103792B (fi) 1999-09-30
EP0420942A1 (en) 1991-04-10
EP0353450A1 (en) 1990-02-07
HU219485B (hu) 2001-04-28
DK49390A (da) 1990-02-23
EP0353450B1 (en) 1995-03-29
JPH04504247A (ja) 1992-07-30
WO1989012631A1 (en) 1989-12-28
GR900300034T1 (en) 1991-07-31
BR8907507A (pt) 1991-06-11
KR900701765A (ko) 1990-12-04
HU894432D0 (en) 1992-02-28
AU3979489A (en) 1990-01-12
AU634167B2 (en) 1993-02-18
DK49390D0 (da) 1990-02-23
CA1341373C (en) 2002-07-02
ES2013978A4 (es) 1990-06-16
IE892045L (en) 1989-12-24
ATE120457T1 (de) 1995-04-15
NO179008B (no) 1996-04-09
DK175393B1 (da) 2004-09-20
NO900869D0 (no) 1990-02-23
FI117889B (fi) 2007-04-13
NO900869L (no) 1990-04-11

Similar Documents

Publication Publication Date Title
FI906368A0 (fi) Makrocykliska bifunktionella kelatbildare, komplex daerav och deras antikroppkonjugat
FI944973A0 (fi) Karboksiamidimodifioituja polyamiinikelaatinmuodostajia ja radioaktiivisia komplekseja ja konjugaatteja
FI883046A (fi) Funktionaliserade kelatbildande polyaminer och rodiumkomplex daerav samt foerfarande foer deras framstaellning.
FI895141A0 (fi) Kelatmedel med orto-ligerande funktionalitet och deras komplexer.
DE69010550D1 (de) Sauerstoffabsorbtion.
DE69005903D1 (de) Verstärkungsgerät mit Differenzverstärkerstufe.
DE3786915D1 (de) Parametrisch geaendertes supraleitendes material.
ES253765U (es) Parque infantil perfeccionado

Legal Events

Date Code Title Description
FG Patent granted

Owner name: THE DOW CHEMICAL COMPANY